Characteristics and external validity of the German Health Risk Institute (HRI) Database
Authors:
- 3 November 2015
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 25 (1) , 106-109
Abstract
Purpose The aim of this study was to describe characteristics and external validity of the German Health Risk Institute (HRI) Database. Methods The HRI Database is an anonymized healthcare database with longitudinal data from approximately six Mio Germans. In addition to demographic information (gender, age, region of residence), data on persistence of insurants over time, hospitalization rates, mortality rates and drug prescription rates were extracted from the HRI database for 2013. Corresponding national reference data were obtained from official sources. Results The proportion of men and women was similar in the HRI Database and Germany, but the database population was slightly younger (mean 40.4 vs 43.7 years). The proportion of insurants living in the eastern part of Germany was lower in the HRI Database (10.1% vs 19.7%). There was good accordance to German reference data with respect to hospitalization rates, overall mortality rate and prescription rates for the 20 most often reimbursed drug classes, with the overall burden of morbidity being slightly lower in the HRI database. From insurants insured on 1 January 2009 (N = 6.2 Mio), a total of 70.6% survived and remained continuously insured with the same statutory health insurance until 31 December 2013. This proportion increased to 77.5% if only insurants ≥40 years were considered. Conclusions There was good overall accordance of the HRI database and the German population in terms of measures of morbidity, mortality and drug usage. Persistence of insurants with the database over time was high, indicating suitability of the data source for longitudinal epidemiological analyses. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
This publication has 7 references indexed in Scilit:
- Mortality in the German Pharmacoepidemiological Research Database (GePaRD) compared to national data in Germany: results from a validation studyBMC Public Health, 2015
- Unterschiede in der Versichertenstruktur von Krankenkassen und deren Auswirkungen für die Versorgungsforschung: Ergebnisse des Bertelsmann-GesundheitsmonitorsDas Gesundheitswesen, 2011
- Regional variation of mortality from ischemic heart disease in Germany from 1998 to 2007Clinical Research in Cardiology, 2010
- Review on use of German health insurance medication claims data for epidemiological researchPharmacoepidemiology and Drug Safety, 2009
- Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitationsPharmacoepidemiology and Drug Safety, 2008
- Versichertenstichprobe AOK Hessen/KV Hessen - Konzeption und Umsetzung einer personenbezogenen Datenbasis aus der Gesetzlichen KrankenversicherungDas Gesundheitswesen, 2005
- Regional variation and time trends in mortality from ischaemic heart disease: East and West Germany 10 years after reunificationJournal of Epidemiology and Community Health, 2004